According to Foghorn Therapeutics's latest financial reports the company's current earnings (TTM) are -โฌ85.7 M. In 2023 the company made an earning of -โฌ97.38 M an increase over its 2022 earnings that were of -โฌ0.11 B.The earnings displayed on this page is the company's Pretax Income.